source
- AstraZeneca and GSK strike new China partnerships with Sino BiopharmSino Biopharm announced two separate agreements with the United Kingdom's largest drugmakers, AstraZeneca and GSK, to deepen their presence in the Chinese market. AstraZeneca will license rights t…
- Arbitration panel rules Prime Medicine did not breach Beam deal over AATD therapyAn arbitration panel has ruled that Prime Medicine did not violate its 2019 collaboration agreement with Beam Therapeutics by advancing a treatment for alpha‑1 antitrypsin deficiency (AATD). The de…